Israel Englander’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-762,640
| Closed | -$165M | – | 7452 |
|
|
2021
Q1 | $165M | Buy |
762,640
+753,780
| +8,508% | +$142M | 0.12% | 114 |
|
|
2020
Q4 | $1.02M | Buy |
+8,860
| New | +$993K | ﹤0.01% | 3725 |
|
|
2020
Q2 | – | Sell |
-50,165
| Closed | -$4.39M | – | 4819 |
|
|
2020
Q1 | $4.39M | Sell |
50,165
-146,824
| -75% | -$15.5M | 0.01% | 1425 |
|
|
2019
Q4 | $20.6M | Sell |
196,989
-656,778
| -77% | -$73.6M | 0.03% | 819 |
|
|
2019
Q3 | $98.2M | Buy |
+853,767
| New | +$130M | 0.16% | 112 |
|
|
2019
Q2 | – | Sell |
-90,279
| Closed | -$15.6M | – | 4677 |
|
|
2019
Q1 | $15.2M | Sell |
90,279
-70,779
| -44% | -$10.5M | 0.02% | 973 |
|
|
2018
Q4 | $15.7M | Buy |
+161,058
| New | +$21.1M | 0.02% | 829 |
|
|
2018
Q3 | – | Sell |
-32,734
| Closed | -$4.57M | – | 4445 |
|
|
2018
Q2 | $4.57M | Sell |
32,734
-207,040
| -86% | -$29.4M | 0.01% | 1873 |
|
|
2018
Q1 | $27M | Buy |
239,774
+41,349
| +21% | +$5.2M | 0.04% | 719 |
|
|
2017
Q4 | $26.2M | Buy |
198,425
+170,792
| +618% | +$20.1M | 0.04% | 733 |
|
|
2017
Q3 | $2.8M | Sell |
27,633
-130,657
| -83% | -$14M | ﹤0.01% | 1991 |
|
|
2017
Q2 | $15.9M | Buy |
158,290
+22,888
| +17% | +$2.46M | 0.03% | 790 |
|
|
2017
Q1 | $16.4M | Sell |
135,402
-109,578
| -45% | -$13.4M | 0.03% | 765 |
|
|
2016
Q4 | $27.4M | Buy |
244,980
+106,642
| +77% | +$12.8M | 0.06% | 471 |
|
|
2016
Q3 | $18.4M | Buy |
138,338
+132,162
| +2,140% | +$12.6M | 0.03% | 615 |
|
|
2016
Q2 | $566K | Sell |
6,176
-477,823
| -99% | -$40.2M | ﹤0.01% | 2434 |
|
|
2016
Q1 | $34.9M | Buy |
483,999
+479,292
| +10,183% | +$26.3M | 0.09% | 272 |
|
|
2015
Q4 | $327K | Sell |
4,707
-25,609
| -84% | -$2.09M | ﹤0.01% | 2873 |
|
|
2015
Q3 | $2.77M | Buy |
30,316
+7,236
| +31% | +$805K | 0.01% | 1702 |
|
|
2015
Q2 | $2.83M | Sell |
23,080
-2,940
| -11% | -$334K | 0.01% | 1712 |
|
|
2015
Q1 | $2.37M | Buy |
26,020
+16,020
| +160% | +$1.3M | ﹤0.01% | 1847 |
|
|
2014
Q4 | $677K | Sell |
10,000
-5,200
| -34% | -$380K | ﹤0.01% | 2785 |
|
|
2014
Q3 | $1.23M | Sell |
15,200
-32,650
| -68% | -$2.89M | ﹤0.01% | 2173 |
|
|
2014
Q2 | $5.13M | Buy |
47,850
+42,756
| +839% | +$2.97M | 0.01% | 1200 |
|
|
2014
Q1 | $302K | Sell |
5,094
-145,803
| -97% | -$8.67M | ﹤0.01% | 2927 |
|
|
2013
Q4 | $6.27M | Buy |
150,897
+85,012
| +129% | +$2.69M | 0.02% | 996 |
|
|
2013
Q3 | $1.14M | Buy |
+65,885
| New | +$757K | ﹤0.01% | 2022 |
|
Other funds holding GWPH
Israel Englander's GWPH Position: Q2 2021 in Review
Israel Englander sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 762,640 shares — an estimated $165M sold.
Israel Englander first reported a position in GWPH in Q3 2013 and held it in 27 quarters. The position peaked at $165M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Israel Englander reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Israel Englander sold 762,640 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $165M.
- Israel Englander first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2013 and held it in 27 quarters.
- Israel Englander's GW Pharmaceuticals Plc American Depositary Shares position peaked at $165M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.